Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Biochim Biophys Acta. 2017 Jan 15;1861(11 Pt B):3024–3029. doi: 10.1016/j.bbagen.2017.01.014

Rewiring Protein Synthesis: From Natural to Synthetic Amino Acids

Yongqiang Fan a, Christopher R Evans a,b, Jiqiang Ling a,b,*
PMCID: PMC5511583  NIHMSID: NIHMS847741  PMID: 28095316

Abstract

Background

The protein synthesis machinery uses 22 natural amino acids as building blocks that faithfully decode the genetic information. Such fidelity is controlled at multiple steps and can be compromised in nature and in the laboratory to rewire protein synthesis with natural and synthetic amino acids.

Scope of review

This review summarizes the major quality control mechanisms during protein synthesis, including aminoacyl-tRNA synthetases, elongation factors, and the ribosome. We will discuss evolution and engineering of such components that allow incorporation of natural and synthetic amino acids at positions that deviate from the standard genetic code.

Major conclusions

The protein synthesis machinery is highly selective, yet not fixed, for the correct amino acids that match the mRNA codons. Ambiguous translation of a codon with multiple amino acids or complete reassignment of a codon with a synthetic amino acid diversifies the proteome.

General significance

Expanding the genetic code with synthetic amino acids through rewiring protein synthesis has broad applications in synthetic biology and chemical biology. Biochemical, structural, and genetic studies of the translational quality control mechanisms are not only crucial to understand the physiological role of translational fidelity and evolution of the genetic code, but also enable us to better design biological parts to expand the proteomes of synthetic organisms.

1. Introduction

The genetic information flows accurately from DNA to messenger RNA (mRNA) and to protein. The standard genetic code features 20 natural amino acids encoding 61 triplet sense codons, with the remaining three codons (TAA, TAG, and TGA) signaling translation termination [1]. In some organisms, certain TGA and TAG codons are recoded by selenocysteine (Sec) and pyrrolysine (Pyl), known as the 21st and 22nd natural amino acids, respectively [1–3]. Except for Sec, each of the 22 amino acids used as protein building blocks is ligated to the correct transfer RNA (tRNA) by a specialized aminoacyl-tRNA synthetase (aaRS) [4] (Figure 1). The resulting aminoacyl-tRNA (aa-tRNA) is delivered to the ribosome by an elongation factor (EF-Tu in bacteria and EF1A in archaea and eukaryotes), and correct matching of tRNA anticodon and mRNA codon leads to peptide elongation. To ensure translational fidelity, multiple quality control mechanisms are utilized by aaRSs, elongation factors, and the ribosome [5–8]. However, such quality control is frequently escaped by many natural amino acids and analogs [9]. For example, L-canavanine is a structural analog of L-arginine produced by higher plants, and causes toxicity to insects through co-translational incorporation into the insect proteome [10]. In the last couple of decades, many laboratories have engineered the protein synthesis machinery to insert a wide variety of synthetic amino acids into proteins [11–14], which have demonstrated broad applications ranging from structural determination, fluorescent labeling, purification of nascent proteins, studies of protein modifications, and engineering of synthetic organisms [14–18]. In this review, we provide an update on the mechanisms of amino acid selection by the protein synthesis machinery, and the implications in cell physiology and synthetic biology.

Figure 1. Amino acid selection during protein synthesis.

Figure 1

Each aminoacyl-tRNA synthetase (e.g., GlnRS, PDB ID: 1EUQ) selectively pairs the cognate amino acid with corresponding tRNA. EF-Tu (PDB ID: 1OB2) then delivers the aa-tRNA to the ribosome, where codon-anticodon match triggers transfer of the amino acid to the growing peptide in the peptidyl-transferase center.

2. Selection of amino acids by aminoacyl-tRNA synthetases

2.1. Selection and editing of natural amino acids by aaRSs and trans-editing factors

Picking the correct amino acid by the aaRS poses a significant challenge due to the structural similarity between some amino acids [19]. For example, valine (Val) and isoleucine (Ile) differ by a small methyl group in the side chain. The initial selection at the active site of isoleucine-tRNA synthetase (IleRS) only provides 180-fold discrimination between Val and Ile [20], which does not satisfy the average amino acid misincorporation rate of approximately 10−4 [21]. Additional proofreading is provided by an appended editing domain in IleRS, which hydrolyzes the misacylated Val-tRNAIle in a post-transfer editing reaction [20]. Editing domains are also present in valyl- (ValRS) [22, 23], leucyl- (LeuRS) [24], prolyl- (ProRS) [25], threonyl- (ThrRS) [26], alanyl- (AlaRS) [27], and phenylalanyl- (PheRS) [28] tRNA synthetases. The editing site specifically hydrolyzes the misacylated aa-tRNA but excludes the correct aa-tRNA, therefore preventing waste of resources. For example, the editing site of PheRS hydrolyzes tyrosyl- and meta-tyrosyl-tRNAPhe, but not Phe-tRNAPhe [28–30]. A conserved glutamate residue in the editing site specifically recognizes the hydroxyl group of tyrosine and meta-tyrosine for substrate selection [30–32] (Figure 2). Besides cis-editing domains within aaRSs, post-transfer editing is also achieved by free-standing trans-editing factors [33, 34]. To date, trans-editing factors that are homologous to the editing domains of ThrRS, AlaRS and ProRS have been identified [33–35]. Unlike cis-editing domains that recognize specific aa-tRNAs, trans-editing factors have recently been shown to exhibit broader substrate recognition patterns [36, 37]. For example, a homolog of the ProRS editing domain (ProXp-y) hydrolyzes Ser-tRNAThr and Thr-tRNAVal produced by ThrRS and ValRS, respectively [36], indicating a generic role of trans-editing factors in the improvement of aminoacylation fidelity.

Figure 2. Substrate selection of PheRS editing site.

Figure 2

The crystal structure of Thermus thermophilus PheRS (PDB ID: 2AMC) reveals that the hydroxyl group of Tyr is recognized by the carboxyl group of E334.

Editing mechanisms of aaRSs are mostly conserved throughout evolution. However, mitochondria and certain organisms with reduced genomes have lost some editing functions. In yeast mitochondria, both PheRS [38] and ThrRS [39, 40] have lost the entire cis-editing domains. Mitochondrial PheRS fidelity is achieved by a more selective active site [38], and mitochondrial ThrRS utilizes an alternate proofreading mechanism, namely pre-transfer editing [41], to reduce aminoacylation errors [40]. Interestingly, PheRS and ThrRS in certain mycoplasma species are also editing-defective [42, 43]. Mycoplasma PheRS and ThrRS with defunct editing sites are intrinsically error-prone and not able to support growth in Escherichia coli and Saccharomyces cerevisiae that have lost their native cytosolic counterparts [43, 44]. It is still unclear why these mycoplasma species have lost the editing function during evolution. One possibility is that reduced translation fidelity is not only tolerated, but may also be advantageous during the life cycle of mycoplasma.

2.2. Stress-induced misacylation

Aminoacylation fidelity is a prerequisite for accurate proteins synthesis. Mutations in the aaRS or tRNA could increase errors during aminoacylation [6]. More recent studies revealed that certain stress conditions also increase specific aminoacylation errors via distinct mechanisms [29, 45–48]. In mammalian cells, viral infection and oxidative stress substantially increase attachment of methionine to noncognate tRNAs [45]. Such global misacylation is induced by phosphorylation of methionyl-tRNA synthetase (MetRS), and may provide transient protection against oxidative stress thanks to reversible oxidation of Met in the proteome [49]. Oxidative stress also leads to misacylation by two other aaRSs – ThrRS and PheRS. The ThrRS editing site contains a conserved cysteine (C182 in Escherichia coli ThrRS) that is essential for the editing activity [26, 50]. We have shown that C182 is sensitive to oxidative stress and can be modified to a sulfenic acid, which can be reverted to cysteine when the oxidative stress is removed [46, 51]. Oxidation of C182 is facilitated by two conserved histidines in the editing site [51], and leads to an editing deficiency and misacylation of serine (Ser) to tRNAThr. C182 thus serves as a redox switch to control ThrRS editing. For PheRS, oxidized Phe is attached to tRNAPhe when the editing activity is compromised [29].

Microorganisms frequently encounter environmental changes. In the hyperthermophilic archaeon Aeropyrum pernix, low temperature enhances misacylation of tRNALeu with Met by MetRS [47], although the underlying mechanism remains unclear. In E. coli, growth under anaerobic conditions suppresses a succinyl-lysine modification of MetRS that is required for high fidelity during aminoacylation, resulting in increased Met misacylation [48]. These recent advances suggest that aminoacylation fidelity is remarkably flexible under stress conditions and likely serve as novel regulatory mechanisms (see discussion below in Physiological impact of rewiring protein synthesis).

2.3. Plasticity of wild-type aaRSs towards synthetic amino acids

Quality control mechanisms in aaRSs have evolved to discriminate against amino acids and analogs that are present in the natural environments. Synthetic amino acids that are structurally similar to the cognate amino acids can be effective substrates for aaRSs. For example, the wild-type PheRS has been shown to activate several Phe analogs [52]. Screening of a synthetic amino acid library reveals that wild-type E. coli tryptophanyl- (TrpRS) and tyrosyl- (TyrRS) tRNA synthetases uses a wide range of synthetic amino acids as substrates [53]. An exciting application that takes advantage of the substrate plasticity of aaRSs is bioorthogonal noncanonical amino acid tagging (BONCAT) [54]. BONCAT uses endogenous MetRS to incorporate a Met analog azidohomoalanine (AHA) into Met positions, and further click chemistry allows fluorescent tagging or purification of the nascent proteome. This residue-specific approach has been broadly used to visualize and quantitate newly synthesized proteins, to probe the dynamics of protein modifications, and to produce new materials [14].

2.4. Engineering of aaRS to expand the genetic code with novel synthetic amino acids

As discussed above, some wild-type aaRSs are capable of activating certain synthetic amino acids. However, such synthetic amino acids need to compete with the cognate amino acid for the aaRS and are often inserted into the entire proteome with low homogeneity. In contrast to residue-specific incorporation of synthetic amino acids, a site-specific approach uses an engineered aaRS/tRNA pair to insert the synthetic amino acid only at particular locations of the target protein, typically mutated to the UAG codon [55]. The most commonly used aaRSs for such purposes are TyrRS from Methanocaldococcus jannaschii, and pyrrolysyl-tRNA synthetase (PylRS) from Methanosarcina species. These systems have been reviewed extensively elsewhere [12, 55, 56]. Recently, this site-specific approach has provided important insights into the dynamics of post-translational modifications, such as lysine acetylation and serine phosphorylation [16, 57]. Another intriguing application of site-specific incorporation of synthetic amino acids is biocontainment. Two recent studies have engineered genetically modified organisms that depend on the addition of a synthetic amino acid for growth, thanks to an engineered aaRS suppressing an in-frame stop codon of an essential gene with the synthetic amino acid [17, 18].

3. Recognition of aminoacyl-tRNAs by elongation factor

Elongation factors deliver a variety of aa-tRNA substrates to the ribosome. However, not all amino acids are recognized with equal efficiency [58]. The amino acid binding pocket of EF-Tu is relatively small and negatively charged [59] (Figure 3); therefore it binds negatively-charged and bulky amino acids with low affinity [7, 58, 60]. For natural proteinogenic amino acids with negative charges, such as glutamate (Glu) and aspartate (Asp), weak binding of the amino acid by EF-Tu is compensated by strong binding of the tRNA moiety [7, 61]. To co-translationally incorporate negatively-charged phosphoserine (Sep) into the proteins, EF-Tu has been engineered to improve recognition of Sep [62]. Similar EF-Tu engineering has been conducted to effectively insert selenocysteine into proteins in a SECIS-independent manner [63]. Not surprisingly, these laboratory-evolved EF-Tu variants contain mutations of negatively-charged or neutral residues to positively-charged arginines in the amino acid binding pocket [62–64]. In addition to EF-Tu engineering, tRNA optimization has also been successfully performed to enhance ribosomal incorporation of long-chain amino acids [65]. In this study, Foster and colleagues engineered a synthetic tRNAAlaB, which is derived from a natural tRNAAla and has high affinity to EF-Tu. Using tRNAAlaB as the tRNA body to carry long-chain amino acids substantially increases EF-Tu affinity and the incorporation speed of synthetic amino acids into peptides [65].

Figure 3. Structure of the amino acid binding pocket of EF-Tu (PDB ID: 1OB2).

Figure 3

Two conserved acidic residues prevent effective binding of negatively-charged amino acids, such as Asp, Glu, phosphoramino acids, and selenocysteine.

4. Discrimination of amino acids by the ribosome

4.1. Recognition of natural proteinogenic amino acids by the ribosome

The ribosome uses 22 natural amino acids to synthesize proteins. When the crystal structure of the large ribosomal subunit was solved, it was found that the amino acid side chain of the aa-tRNA directly contacts the rRNA residues in the ribosomal aa-tRNA binding (A) site [66], suggesting that different amino acids may be recognized by the ribosome with distinct efficiencies. Later in vitro kinetic studies showed that amino acid side chains of aa-tRNAs do contribute to ribosome binding [61, 67]. Fast kinetic analyses of dipeptide formation revealed that the N-alkylamino acid proline (Pro) is a poor substrate for peptide elongation on the purified ribosome [68]. In vivo, a specialized elongation factor (EF-P in bacteria and eIF5A in eukaryotes) promotes efficient translation of Pro codons [69–71]. Enhancement of Pro translation by EF-P or eIF5A requires diverse post-translational modifications, including β-lysylation in E. coli and Salmonella [72, 73], rhamnosylation in Pseudomonas auruginosa [74], lysine modification with 5-aminopentanol group in Bacillus [75], and hypusine in yeast [71].

4.2. Ribosomal translation of D- and β-amino acids

Ribosomes use L-α-amino acids as building blocks for peptides. D- and β-amino acids (Figure 4) attached to the tRNA have been shown to be poor substrates for the wild-type ribosome [76]. Hecht and colleagues tested ribosome variants with mutations in the peptidyl-transferase center, and found several ribosome mutants with substantially increased efficiency to incorporate D-amino acids into a reporter protein in vitro [77]. A recent study by Englander et al. provided mechanistic insights into discrimination of D-amino acids by the wild-type ribosome [78]. It was shown that D-aa-tRNAs are accepted by the ribosomal A site and used as substrates for peptide formation. However, ribosomes with D-amino acid in the peptidyl-tRNA (P) site are partitioned into translating and arrested subpopulations, therefore impeding further peptide elongation [78].

Figure 4. Structures of amino acids with different backbones.

Figure 4

D- and β-amino acids are discriminated against by the wild-type ribosome, but can be co-translationally inserted into peptides by certain mutant ribosomes.

Similar to D-amino acids, β-amino acids have also been inserted into peptides by mutant ribosomes in vitro [79, 80]. A recent study shows that some β-amino acids can even be used by the wild-type ribosome as substrates [81]. Ribosomal incorporation of β-amino acids into proteins has also been achieved in vivo [82]. Using mutant ribosomes and endogenous aaRSs and EF-Tu, Czekster et al. successfully inserted β-Phe analogs into reporter proteins in E. coli [82]. Including D- and β-amino acids in the protein alphabet will significantly expand the toolbox for de novo protein design [83]. Synthetic peptides containing D- and β-amino acids can be used as new biomaterials with novel properties, such as resistance to degradation by proteases. D-amino acids are key components of the bacterial cell wall and many antibiotics. Site-specific insertion of D-amino acids into peptides could also have potential applications in the development of novel antimicrobial strategies.

5. Physiological impact of rewiring protein synthesis

5.1. Fitness costs of rewiring protein synthesis

Rewiring protein synthesis with natural or synthetic amino acids leads to production of novel proteomes comprised of proteins with noncononical sequences. Many proteins with amino acid replacements fail to fold correctly and even form aggregates [84–86], causing both gain of toxicity and loss of function [29, 87, 88]. Reduced translational fidelity causes various cell defects, ranging from growth defects and cell death in bacteria [89–91], mitochondrial dysfunction in yeast [92], shortened life span in flies [93], and neurodegeneration and cardioproteinopathy in mammals [85, 94]. Editing defects in aaRS further increase DNA mutations in bacteria [95] and activates DNA damage response in zebrafish [96]. Recent work also suggests that a PheRS editing defect suppresses stringent response in E. coli [97], and a ribosomal error-prone mutation suppresses bacterial motility [98].

In addition to reduced translational fidelity, genome-wide codon reasignment also leads to reduced fitness. In Methanosarcina acetivorans, deleting the tRNAPyl gene reduces the genetic code from 21 to 20 amino acids, which causes downregulation of amino acid metabolism and growth defects in methanol [99]. This work suggests a selective advantage of an expanded genetic code in nature. In another study, evolved E. coli cells that completely replaces Trp with an analog (Tpa) in the proteome appear longer and thinner, and need to accummulate beneficial mutations to support robust growth [100].

5.2. Benefits of reduced translational fidelity

Despite the fitness cost of translational errors, reduced translational fidelity paradoxically provides benefits under certain stress conditions [101, 102]. In Candida albicans, ambiguos translation of CUG codons with Ser and Leu increases phenotypic diversity [103]. In the budding yeast, depletion of a release factor that forms prion increases resistance of cells to various stresses [104]. Further, methionine misacylation has been suggested to increase cell resistance to oxidative stress [45] and antibiotics [48], and produce alternate protein variants that better adapt to low temperatures [47]. We have also shown that reduced translation fidelity caused by a ribosomal mutation or canavanine improves bacterial tolerance to oxidative stress by activating the general stress response [105]. Reduced translational fidelity may also directly modify drug targets to increase resistance. For example, in Mycobacteria, mistranslation of glutamine (Gln) and asparagine (Asn) codons with Glu and Asp in the RpoB protein creates variant proteins that resist rifampicin [106, 107].

6. Conclusions and perspectives

The flexibility of the genetic code has been demonstrated in numerous cases from natural evolution and adaptation to laboratory engineering. Increased knowledge of the mechanisms and physiological impact of rewired protein synthesis has reshaped our understanding of evolution, microbial pathogenesis, and synthetic biology. In future studies, novel sensitive tools need to be developed to detect alternate translation events in microorganisms and higher eukaryotes under native environments. To further understand evolution and the physiological role of translational fidelity and facilitate design of synthetic organisms with altered proteomes, genetically-modified model organisms and systems are warranted. In addition, the role of translational errors on protein misfolding and human diseases needs to be clarified.

Highlights.

  • The protein synthesis machinery is selective for natural amino acid substrates

  • Translational fidelity can be compromised under stress conditions

  • Engineering of aaRSs, EF-Tu, and the ribosome expands the genetic code

Acknowledgments

This work was funded by NIGMS R01GM115431 (J.L.),

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Ling J, O’Donoghue P, Söll D. Genetic code flexibility in microorganisms: novel mechanisms and impact on physiology. Nat Rev Microbiol. 2015;13:707–721. doi: 10.1038/nrmicro3568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ambrogelly A, Palioura S, Söll D. Natural expansion of the genetic code. Nat Chem Biol. 2007;3:29–35. doi: 10.1038/nchembio847. [DOI] [PubMed] [Google Scholar]
  • 3.Hao B, Gong W, Ferguson TK, James CM, Krzycki JA, Chan MK. A new UAG-encoded residue in the structure of a methanogen methyltransferase. Science. 2002;296:1462–1466. doi: 10.1126/science.1069556. [DOI] [PubMed] [Google Scholar]
  • 4.Ibba M, Söll D. Aminoacyl-tRNAs: setting the limits of the genetic code. Genes Dev. 2004;18:731–738. doi: 10.1101/gad.1187404. [DOI] [PubMed] [Google Scholar]
  • 5.Mascarenhas AP, An S, Rosen AE, Martinis SA, Musier-Forsyth K. Fidelity mechanisms of the aminoacyl-tRNA synthetases. In: RajBhandary UL, Köhrer C, editors. Protein Engineering. Springer-Verlag; New York: 2008. pp. 153–200. [Google Scholar]
  • 6.Ling J, Reynolds N, Ibba M. Aminoacyl-tRNA synthesis and translational quality control. Annu Rev Microbiol. 2009;63:61–78. doi: 10.1146/annurev.micro.091208.073210. [DOI] [PubMed] [Google Scholar]
  • 7.Dale T, Uhlenbeck OC. Amino acid specificity in translation. Trends Biochem Sci. 2005;30:659–665. doi: 10.1016/j.tibs.2005.10.006. [DOI] [PubMed] [Google Scholar]
  • 8.Zaher HS, Green R. Fidelity at the molecular level: lessons from protein synthesis. Cell. 2009;136:746–762. doi: 10.1016/j.cell.2009.01.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Bullwinkle T, Lazazzera B, Ibba M. Quality control and infiltration of translation by amino acids outside of the genetic code. Annu Rev Genet. 2014;48:149–166. doi: 10.1146/annurev-genet-120213-092101. [DOI] [PubMed] [Google Scholar]
  • 10.Rosenthal GA. The biological effects and mode of action of L-canavanine, a structural analogue of L-arginine. Q Rev Biol. 1977;52:155–178. doi: 10.1086/409853. [DOI] [PubMed] [Google Scholar]
  • 11.Liu CC, Schultz PG. Adding new chemistries to the genetic code. Annu Rev Biochem. 2010;79:413–444. doi: 10.1146/annurev.biochem.052308.105824. [DOI] [PubMed] [Google Scholar]
  • 12.Chin JW. Expanding and reprogramming the genetic code of cells and animals. Annu Rev Biochem. 2014;83:379–408. doi: 10.1146/annurev-biochem-060713-035737. [DOI] [PubMed] [Google Scholar]
  • 13.Wang YS, Fang X, Wallace AL, Wu B, Liu WR. A rationally designed pyrrolysyl-tRNA synthetase mutant with a broad substrate spectrum. J Am Chem Soc. 2012;134:2950–2953. doi: 10.1021/ja211972x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Johnson JA, Lu YY, Van Deventer JA, Tirrell DA. Residue-specific incorporation of non-canonical amino acids into proteins: recent developments and applications. Curr Opin Chem Biol. 2010;14:774–780. doi: 10.1016/j.cbpa.2010.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hendrickson WA, Horton JR, LeMaster DM. Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. The EMBO journal. 1990;9:1665–1672. doi: 10.1002/j.1460-2075.1990.tb08287.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Yang A, Ha S, Ahn J, Kim R, Kim S, Lee Y, Kim J, Soll D, Lee HY, Park HS. A chemical biology route to site-specific authentic protein modifications. Science. 2016 doi: 10.1126/science.aah4428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mandell DJ, Lajoie MJ, Mee MT, Takeuchi R, Kuznetsov G, Norville JE, Gregg CJ, Stoddard BL, Church GM. Biocontainment of genetically modified organisms by synthetic protein design. Nature. 2015;518:55–60. doi: 10.1038/nature14121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rovner AJ, Haimovich AD, Katz SR, Li Z, Grome MW, Gassaway BM, Amiram M, Patel JR, Gallagher RR, Rinehart J, Isaacs FJ. Recoded organisms engineered to depend on synthetic amino acids. Nature. 2015;518:89–93. doi: 10.1038/nature14095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ibba M, Francklyn CS, Cusack S. The aminoacyl-tRNA synthetases. Taylor & Francis; 2005. [Google Scholar]
  • 20.Schmidt E, Schimmel P. Mutational isolation of a sieve for editing in a transfer RNA synthetase. Science. 1994;264:265–267. doi: 10.1126/science.8146659. [DOI] [PubMed] [Google Scholar]
  • 21.Loftfield RB, Vanderjagt D. The frequency of errors in protein biosynthesis. Biochem J. 1972;128:1353–1356. doi: 10.1042/bj1281353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fukai S, Nureki O, Sekine S, Shimada A, Tao J, Vassylyev DG, Yokoyama S. Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNAVal and valyl-tRNA synthetase. Cell. 2000;103:793–803. doi: 10.1016/s0092-8674(00)00182-3. [DOI] [PubMed] [Google Scholar]
  • 23.Fersht AR, Kaethner MM. Enzyme hyperspecificity. Rejection of threonine by the valyl-tRNA synthetase by misacylation and hydrolytic editing. Biochemistry. 1976;15:3342–3346. doi: 10.1021/bi00660a026. [DOI] [PubMed] [Google Scholar]
  • 24.Lincecum TL, Jr, Tukalo M, Yaremchuk A, Mursinna RS, Williams AM, Sproat BS, Van Den EW, Link A, Van Calenbergh S, Grotli M, Martinis SA, Cusack S. Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase. Mol Cell. 2003;11:951–963. doi: 10.1016/s1097-2765(03)00098-4. [DOI] [PubMed] [Google Scholar]
  • 25.Beuning PJ, Musier-Forsyth K. Hydrolytic editing by a class II aminoacyl-tRNA synthetase. Proc Natl Acad Sci USA. 2000;97:8916–8920. doi: 10.1073/pnas.97.16.8916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dock-Bregeon A, Sankaranarayanan R, Romby P, Caillet J, Springer M, Rees B, Francklyn CS, Ehresmann C, Moras D. Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem. Cell. 2000;103:877–884. doi: 10.1016/s0092-8674(00)00191-4. [DOI] [PubMed] [Google Scholar]
  • 27.Beebe K, Ribas de Pouplana L, Schimmel P. Elucidation of tRNA-dependent editing by a class II tRNA synthetase and significance for cell viability. EMBO J. 2003;22:668–675. doi: 10.1093/emboj/cdg065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Roy H, Ling J, Irnov M, Ibba M. Post-transfer editing in vitro and in vivo by the beta subunit of phenylalanyl-tRNA synthetase. EMBO J. 2004;23:4639–4648. doi: 10.1038/sj.emboj.7600474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bullwinkle T, Reynolds NM, Raina M, Moghal AB, Matsa E, Rajkovic A, Kayadibi H, Fazlollahi F, Ryan C, Howitz N, Faull KF, Lazazzera B, Ibba M. Oxidation of cellular amino acid pools leads to cytotoxic mistranslation of the genetic code. eLife. 2014:e02501. doi: 10.7554/eLife.02501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Klipcan L, Moor N, Kessler N, Safro MG. Eukaryotic cytosolic and mitochondrial phenylalanyl-tRNA synthetases catalyze the charging of tRNA with the meta-tyrosine. Proc Natl Acad Sci USA. 2009;106:11045–11048. doi: 10.1073/pnas.0905212106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Moor N, Kotik-Kogan O, Tworowski D, Sukhanova M, Safro M. The crystal structure of the ternary complex of phenylalanyl-tRNA synthetase with tRNAPhe and a phenylalanyl-adenylate analogue reveals a conformational switch of the CCA end. Biochemistry. 2006;45:10572–10583. doi: 10.1021/bi060491l. [DOI] [PubMed] [Google Scholar]
  • 32.Ling J, Roy H, Ibba M. Mechanism of tRNA-dependent editing in translational quality control. Proc Natl Acad Sci USA. 2007;104:72–77. doi: 10.1073/pnas.0606272104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.An S, Musier-Forsyth K. Trans-editing of Cys-tRNAPro by Haemophilus influenzae YbaK protein. J Biol Chem. 2004;279:42359–42362. doi: 10.1074/jbc.C400304200. [DOI] [PubMed] [Google Scholar]
  • 34.Ahel I, Korencic D, Ibba M, Söll D. Trans-editing of mischarged tRNAs. Proc Natl Acad Sci USA. 2003;100:15422–15427. doi: 10.1073/pnas.2136934100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Guo M, Chong YE, Shapiro R, Beebe K, Yang XL, Schimmel P. Paradox of mistranslation of serine for alanine caused by AlaRS recognition dilemma. Nature. 2009;462:808–812. doi: 10.1038/nature08612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Liu Z, Vargas-Rodriguez O, Goto Y, Novoa EM, Ribas de Pouplana L, Suga H, Musier-Forsyth K. Homologous trans-editing factors with broad tRNA specificity prevent mistranslation caused by serine/threonine misactivation. Proc Natl Acad Sci USA. 2015;112:6027–6032. doi: 10.1073/pnas.1423664112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Novoa EM, Vargas-Rodriguez O, Lange S, Goto Y, Suga H, Musier-Forsyth K, Ribas de Pouplana L. Ancestral AlaX editing enzymes for control of genetic code fidelity are not tRNA-specific. The Journal of biological chemistry. 2015;290:10495–10503. doi: 10.1074/jbc.M115.640060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Roy H, Ling J, Alfonzo J, Ibba M. Loss of editing activity during the evolution of mitochondrial phenylalanyl-tRNA synthetase. J Biol Chem. 2005;280:38186–38192. doi: 10.1074/jbc.M508281200. [DOI] [PubMed] [Google Scholar]
  • 39.Ling J, Peterson KM, Simonovic I, Cho C, Söll D, Simonovic M. Yeast mitochondrial threonyl-tRNA synthetase recognizes tRNA isoacceptors by distinct mechanisms and promotes CUN codon reassignment. Proc Natl Acad Sci USA. 2012;109:3281–3286. doi: 10.1073/pnas.1200109109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ling J, Peterson KM, Simonovic I, Söll D, Simonovic M. The mechanism of pre-transfer editing in yeast mitochondrial threonyl-tRNA synthetase. J Biol Chem. 2012;287:28518–28525. doi: 10.1074/jbc.M112.372920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Martinis SA, Boniecki MT. The balance between pre- and post-transfer editing in tRNA synthetases. FEBS Lett. 2010;584:455–459. doi: 10.1016/j.febslet.2009.11.071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Li L, Boniecki MT, Jaffe JD, Imai BS, Yau PM, Luthey-Schulten ZA, Martinis SA. Naturally occurring aminoacyl-tRNA synthetases editing-domain mutations that cause mistranslation in Mycoplasma parasites. Proc Natl Acad Sci USA. 2011;108:9378–9383. doi: 10.1073/pnas.1016460108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Yadavalli SS, Ibba M. Selection of tRNA charging quality control mechanisms that increase mistranslation of the genetic code. Nucleic Acids Res. 2013;41:1104–1112. doi: 10.1093/nar/gks1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Zhou XL, Chen Y, Fang ZP, Ruan ZR, Wang Y, Liu RJ, Xue MQ, Wang ED. Translational Quality Control by Bacterial Threonyl-tRNA Synthetases. J Biol Chem. 2016 doi: 10.1074/jbc.M116.740472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Netzer N, Goodenbour JM, David A, Dittmar KA, Jones RB, Schneider JR, Boone D, Eves EM, Rosner MR, Gibbs JS, Embry A, Dolan B, Das S, Hickman HD, Berglund P, Bennink JR, Yewdell JW, Pan T. Innate immune and chemically triggered oxidative stress modifies translational fidelity. Nature. 2009;462:522–526. doi: 10.1038/nature08576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Ling J, Söll D. Severe oxidative stress induces protein mistranslation through impairment of an aminoacyl-tRNA synthetase editing site. Proc Natl Acad Sci USA. 2010;107:4028–4033. doi: 10.1073/pnas.1000315107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Schwartz MH, Pan T. Temperature dependent mistranslation in a hyperthermophile adapts proteins to lower temperatures. Nucleic Acids Res. 2016;44:294–303. doi: 10.1093/nar/gkv1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Schwartz MH, Waldbauer JR, Zhang L, Pan T. Global tRNA misacylation induced by anaerobiosis and antibiotic exposure broadly increases stress resistance in Escherichia coli. Nucleic Acids Res. 2016 doi: 10.1093/nar/gkw856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Lee JY, Kim DG, Kim BG, Yang WS, Hong J, Kang T, Oh YS, Kim KR, Han BW, Hwang BJ, Kang BS, Kang MS, Kim MH, Kwon NH, Kim S. Promiscuous methionyl-tRNA synthetase mediates adaptive mistranslation to protect cells against oxidative stress. J Cell Sci. 2014;127:4234–4245. doi: 10.1242/jcs.152470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Waas WF, Schimmel P. Evidence that tRNA synthetase-directed proton transfer stops mistranslation. Biochemistry. 2007;46:12062–12070. doi: 10.1021/bi7007454. [DOI] [PubMed] [Google Scholar]
  • 51.Wu J, Fan Y, Ling J. Mechanism of oxidant-induced mistranslation by threonyl-tRNA synthetase. Nucleic Acids Res. 2014;42:6523–6531. doi: 10.1093/nar/gku271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Ibba M, Kast P, Hennecke H. Substrate specificity is determined by amino acid binding pocket size in Escherichia coli phenylalanyl-tRNA synthetase. Biochemistry. 1994;33:7107–7112. doi: 10.1021/bi00189a013. [DOI] [PubMed] [Google Scholar]
  • 53.Fan C, Ho JM, Chirathivat N, Soll D, Wang YS. Exploring the substrate range of wild-type aminoacyl-tRNA synthetases. Chembiochem: a European journal of chemical biology. 2014;15:1805–1809. doi: 10.1002/cbic.201402083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Dieterich DC, Link AJ, Graumann J, Tirrell DA, Schuman EM. Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT) Proc Natl Acad Sci USA. 2006;103:9482–9487. doi: 10.1073/pnas.0601637103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wang L, Xie J, Schultz PG. Expanding the genetic code. Annu Rev Biophys Biomol Struct. 2006;35:225–249. doi: 10.1146/annurev.biophys.35.101105.121507. [DOI] [PubMed] [Google Scholar]
  • 56.O’Donoghue P, Ling J, Wang YS, Söll D. Upgrading protein synthesis for synthetic biology. Nat Chem Biol. 2013;9:594–598. doi: 10.1038/nchembio.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Hsu WW, Wu B, Liu WR. Sirtuins 1 and 2 Are Universal Histone Deacetylases. ACS Chem Biol. 2016;11:792–799. doi: 10.1021/acschembio.5b00886. [DOI] [PubMed] [Google Scholar]
  • 58.Dale T, Sanderson LE, Uhlenbeck OC. The affinity of elongation factor Tu for an aminoacyl-tRNA is modulated by the esterified amino acid. Biochemistry. 2004;43:6159–6166. doi: 10.1021/bi036290o. [DOI] [PubMed] [Google Scholar]
  • 59.Nissen P, Kjeldgaard M, Thirup S, Polekhina G, Reshetnikova L, Clark BF, Nyborg J. Crystal structure of the ternary complex of Phe-tRNAPhe, EF-Tu, and a GTP analog. Science. 1995;270:1464–1472. doi: 10.1126/science.270.5241.1464. [DOI] [PubMed] [Google Scholar]
  • 60.Ieong KW, Pavlov MY, Kwiatkowski M, Forster AC, Ehrenberg M. Inefficient delivery but fast peptide bond formation of unnatural L-aminoacyl-tRNAs in translation. Journal of the American Chemical Society. 2012;134:17955–17962. doi: 10.1021/ja3063524. [DOI] [PubMed] [Google Scholar]
  • 61.Fahlman RP, Dale T, Uhlenbeck OC. Uniform binding of aminoacylated transfer RNAs to the ribosomal A and P sites. Mol Cell. 2004;16:799–805. doi: 10.1016/j.molcel.2004.10.030. [DOI] [PubMed] [Google Scholar]
  • 62.Park HS, Hohn MJ, Umehara T, Guo LT, Osborne EM, Benner J, Noren CJ, Rinehart J, Söll D. Expanding the genetic code of Escherichia coli with phosphoserine. Science. 2011;333:1151–1154. doi: 10.1126/science.1207203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Haruna K, Alkazemi MH, Liu Y, Soll D, Englert M. Engineering the elongation factor Tu for efficient selenoprotein synthesis. Nucleic acids research. 2014;42:9976–9983. doi: 10.1093/nar/gku691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Fan C, Ip K, Soll D. Expanding the genetic code of Escherichia coli with phosphotyrosine. FEBS letters. 2016 doi: 10.1002/1873-3468.12333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Ieong KW, Pavlov MY, Kwiatkowski M, Ehrenberg M, Forster AC. A tRNA body with high affinity for EF-Tu hastens ribosomal incorporation of unnatural amino acids. RNA. 2014;20:632–643. doi: 10.1261/rna.042234.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Nissen P, Hansen J, Ban N, Moore PB, Steitz TA. The structural basis of ribosome activity in peptide bond synthesis. Science. 2000;289:920–930. doi: 10.1126/science.289.5481.920. [DOI] [PubMed] [Google Scholar]
  • 67.Fahlman RP, Uhlenbeck OC. Contribution of the esterified amino acid to the binding of aminoacylated tRNAs to the ribosomal P- and A-sites. Biochemistry. 2004;43:7575–7583. doi: 10.1021/bi0495836. [DOI] [PubMed] [Google Scholar]
  • 68.Pavlov MY, Watts RE, Tan Z, Cornish VW, Ehrenberg M, Forster AC. Slow peptide bond formation by proline and other N-alkylamino acids in translation. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:50–54. doi: 10.1073/pnas.0809211106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Ude S, Lassak J, Starosta AL, Kraxenberger T, Wilson DN, Jung K. Translation elongation factor EF-P alleviates ribosome stalling at polyproline stretches. Science. 2013;339:82–85. doi: 10.1126/science.1228985. [DOI] [PubMed] [Google Scholar]
  • 70.Doerfel LK, Wohlgemuth I, Kothe C, Peske F, Urlaub H, Rodnina MV. EF-P is essential for rapid synthesis of proteins containing consecutive proline residues. Science. 2013;339:85–88. doi: 10.1126/science.1229017. [DOI] [PubMed] [Google Scholar]
  • 71.Gutierrez E, Shin BS, Woolstenhulme CJ, Kim JR, Saini P, Buskirk AR, Dever TE. eIF5A promotes translation of polyproline motifs. Molecular cell. 2013;51:35–45. doi: 10.1016/j.molcel.2013.04.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Roy H, Zou SB, Bullwinkle TJ, Wolfe BS, Gilreath MS, Forsyth CJ, Navarre WW, Ibba M. The tRNA synthetase paralog PoxA modifies elongation factor-P with (R)-beta-lysine. Nat Chem Biol. 2011;7:667–669. doi: 10.1038/nchembio.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Bullwinkle TJ, Zou SB, Rajkovic A, Hersch SJ, Elgamal S, Robinson N, Smil D, Bolshan Y, Navarre WW, Ibba M. (R)-beta-lysine-modified elongation factor P functions in translation elongation. The Journal of biological chemistry. 2013;288:4416–4423. doi: 10.1074/jbc.M112.438879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Rajkovic A, Erickson S, Witzky A, Branson OE, Seo J, Gafken PR, Frietas MA, Whitelegge JP, Faull KF, Navarre W, Darwin AJ, Ibba M. Cyclic Rhamnosylated Elongation Factor P Establishes Antibiotic Resistance in Pseudomonas aeruginosa. mBio. 2015;6:e00823. doi: 10.1128/mBio.00823-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Rajkovic A, Hummels KR, Witzky A, Erickson S, Gafken PR, Whitelegge JP, Faull KF, Kearns DB, Ibba M. Translation Control of Swarming Proficiency in Bacillus subtilis by 5-Amino-pentanolylated Elongation Factor P. The Journal of biological chemistry. 2016;291:10976–10985. doi: 10.1074/jbc.M115.712091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Tan Z, Forster AC, Blacklow SC, Cornish VW. Amino acid backbone specificity of the Escherichia coli translation machinery. Journal of the American Chemical Society. 2004;126:12752–12753. doi: 10.1021/ja0472174. [DOI] [PubMed] [Google Scholar]
  • 77.Dedkova LM, Fahmi NE, Golovine SY, Hecht SM. Enhanced D-amino acid incorporation into protein by modified ribosomes. Journal of the American Chemical Society. 2003;125:6616–6617. doi: 10.1021/ja035141q. [DOI] [PubMed] [Google Scholar]
  • 78.Englander MT, Avins JL, Fleisher RC, Liu B, Effraim PR, Wang J, Schulten K, Leyh TS, Gonzalez RL, Jr, Cornish VW. The ribosome can discriminate the chirality of amino acids within its peptidyl-transferase center. Proc Natl Acad Sci USA. 2015;112:6038–6043. doi: 10.1073/pnas.1424712112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Dedkova LM, Fahmi NE, Paul R, del Rosario M, Zhang L, Chen S, Feder G, Hecht SM. beta-Puromycin selection of modified ribosomes for in vitro incorporation of beta-amino acids. Biochemistry. 2012;51:401–415. doi: 10.1021/bi2016124. [DOI] [PubMed] [Google Scholar]
  • 80.Maini R, Chowdhury SR, Dedkova LM, Roy B, Daskalova SM, Paul R, Chen S, Hecht SM. Protein Synthesis with Ribosomes Selected for the Incorporation of beta-Amino Acids. Biochemistry. 2015 doi: 10.1021/acs.biochem.5b00389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Fujino T, Goto Y, Suga H, Murakami H. Ribosomal Synthesis of Peptides with Multiple beta-Amino Acids. Journal of the American Chemical Society. 2016 doi: 10.1021/jacs.5b12482. [DOI] [PubMed] [Google Scholar]
  • 82.Melo Czekster C, Robertson WE, Walker AS, Soll D, Schepartz A. In Vivo Biosynthesis of a beta-Amino Acid-Containing Protein. Journal of the American Chemical Society. 2016;138:5194–5197. doi: 10.1021/jacs.6b01023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Achenbach J, Jahnz M, Bethge L, Paal K, Jung M, Schuster M, Albrecht R, Jarosch F, Nierhaus KH, Klussmann S. Outwitting EF-Tu and the ribosome: translation with d-amino acids. Nucleic acids research. 2015 doi: 10.1093/nar/gkv566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Nangle LA, Motta CM, Schimmel P. Global effects of mistranslation from an editing defect in mammalian cells. Chem Biol. 2006;13:1091–1100. doi: 10.1016/j.chembiol.2006.08.011. [DOI] [PubMed] [Google Scholar]
  • 85.Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA, Davisson MT, Sundberg JP, Schimmel P, Ackerman SL. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature. 2006;443:50–55. doi: 10.1038/nature05096. [DOI] [PubMed] [Google Scholar]
  • 86.Ling J, Cho C, Guo LT, Aerni HR, Rinehart J, Söll D. Protein aggregation caused by aminoglycoside action is prevented by a hydrogen peroxide scavenger. Mol Cell. 2012;48:713–722. doi: 10.1016/j.molcel.2012.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Reynolds NM, Lazazzera BA, Ibba M. Cellular mechanisms that control mistranslation. Nat Rev Microbiol. 2010;8:849–856. doi: 10.1038/nrmicro2472. [DOI] [PubMed] [Google Scholar]
  • 88.Drummond DA, Wilke CO. The evolutionary consequences of erroneous protein synthesis. Nat Rev Genet. 2009;10:715–724. doi: 10.1038/nrg2662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Davis BD. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev. 1987;51:341–350. doi: 10.1128/mr.51.3.341-350.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Karkhanis VA, Mascarenhas AP, Martinis SA. Amino acid toxicities of Escherichia coli that are prevented by leucyl-tRNA synthetase amino acid editing. J Bacteriol. 2007;189:8765–8768. doi: 10.1128/JB.01215-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Bacher JM, Crécy-Lagard V, Schimmel PR. Inhibited cell growth and protein functional changes from an editing-defective tRNA synthetase. Proc Natl Acad Sci USA. 2005;102:1697–1701. doi: 10.1073/pnas.0409064102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Reynolds NM, Ling J, Roy H, Banerjee R, Repasky SE, Hamel P, Ibba M. Cell-specific differences in the requirements for translation quality control. Proc Natl Acad Sci USA. 2010;107:4063–4068. doi: 10.1073/pnas.0909640107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Lu J, Bergert M, Walther A, Suter B. Double-sieving-defective aminoacyl-tRNA synthetase causes protein mistranslation and affects cellular physiology and development. Nature communications. 2014;5:5650. doi: 10.1038/ncomms6650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Liu Y, Satz JS, Vo MN, Nangle LA, Schimmel P, Ackerman SL. Deficiencies in tRNA synthetase editing activity cause cardioproteinopathy. Proc Natl Acad Sci USA. 2014;111:17570–17575. doi: 10.1073/pnas.1420196111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Bacher JM, Schimmel P. An editing-defective aminoacyl-tRNA synthetase is mutagenic in aging bacteria via the SOS response. Proc Natl Acad Sci USA. 2007;104:1907–1912. doi: 10.1073/pnas.0610835104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Song Y, Shi Y, Carland TM, Lian S, Sasaki T, Schork NJ, Head SR, Kishi S, Schimmel P. p53-Dependent DNA damage response sensitive to editing-defective tRNA synthetase in zebrafish. Proceedings of the National Academy of Sciences of the United States of America. 2016;113:8460–8465. doi: 10.1073/pnas.1608139113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Bullwinkle TJ, Ibba M. Translation quality control is critical for bacterial responses to amino acid stress. Proc Natl Acad Sci USA. 2016;113:2252–2257. doi: 10.1073/pnas.1525206113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Fan Y, Evans CR, Ling J. Reduced protein synthesis fidelity Inhibits flagellar biosynthesis and motility. Sci Rep. 2016;6:30960. doi: 10.1038/srep30960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.O’Donoghue P, Prat L, Kucklick M, Schafer JG, Riedel K, Rinehart J, Soll D, Heinemann IU. Reducing the genetic code induces massive rearrangement of the proteome. Proceedings of the National Academy of Sciences of the United States of America. 2014;111:17206–17211. doi: 10.1073/pnas.1420193111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Hoesl MG, Oehm S, Durkin P, Darmon E, Peil L, Aerni HR, Rappsilber J, Rinehart J, Leach D, Soll D, Budisa N. Chemical evolution of a bacterial proteome. Angew Chem Int Ed Engl. 2015;54:10030–10034. doi: 10.1002/anie.201502868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Pan T. Adaptive translation as a mechanism of stress response and adaptation. Annu Rev Genet. 2013;47:121–137. doi: 10.1146/annurev-genet-111212-133522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Pouplana LR, Santos MA, Zhu JH, Farabaugh PJ, Javid B. Protein mistranslation: friend or foe? Trends Biochem Sci. 2014;39:355–362. doi: 10.1016/j.tibs.2014.06.002. [DOI] [PubMed] [Google Scholar]
  • 103.Bezerra AR, Simoes J, Lee W, Rung J, Weil T, Gut IG, Gut M, Bayes M, Rizzetto L, Cavalieri D, Giovannini G, Bozza S, Romani L, Kapushesky M, Moura GR, Santos MA. Reversion of a fungal genetic code alteration links proteome instability with genomic and phenotypic diversification. Proc Natl Acad Sci USA. 2013;110:11079–11084. doi: 10.1073/pnas.1302094110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature. 2000;407:477–483. doi: 10.1038/35035005. [DOI] [PubMed] [Google Scholar]
  • 105.Fan Y, Wu J, Ung MH, De Lay N, Cheng C, Ling J. Protein mistranslation protects bacteria against oxidative stress. Nucleic Acids Res. 2015;43:1740–1748. doi: 10.1093/nar/gku1404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Su HW, Zhu JH, Li H, Cai RJ, Ealand C, Wang X, Chen YX, Kayani MU, Zhu TF, Moradigaravand D, Huang H, Kana BD, Javid B. The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity. Nat Microbiol. 2016;1:16147. doi: 10.1038/nmicrobiol.2016.147. [DOI] [PubMed] [Google Scholar]
  • 107.Javid B, Sorrentino F, Toosky M, Zheng W, Pinkham JT, Jain N, Pan M, Deighan P, Rubin EJ. Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance. Proc Natl Acad Sci USA. 2014;111:1132–1137. doi: 10.1073/pnas.1317580111. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES